These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9261885)

  • 1. Mechanism(S) of interferon inhibitory activity in blood from patients with AIDS and patients with lupus erythematosus with vasculitis.
    Ambrus JL; Ambrus JL; Chadha S; Novick D; Rubinstein M; Gopalakrishnan B; Bernstein Z; Priore RL; Chadha KC
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):255-65. PubMed ID: 9261885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon inhibitor in the blood of patients with systemic lupus erythematosus.
    Chadha KC; Ambrus JL; Stadler I; Ambrus JL
    J Biol Regul Homeost Agents; 1991; 5(1):1-9. PubMed ID: 1715634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations].
    Alpa M; Ferrero B; Cavallo R; Naretto C; Gennaro M; Bellizia L; Sena LM; Roccatello D
    G Ital Nefrol; 2002; 19(6):617-21. PubMed ID: 12508165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM; El-Kerdany TH
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serological screening of autoantigens associated with vasculitis in systemic lupus erythematosus].
    Qin W; Feng SG; Deng HX; Fan JM; Zhou Q; Wei YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):132-4, 149. PubMed ID: 17294748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis.
    Hooks JJ; Jordan GW; Cupps T; Moutsopoulos HM; Fauci AS; Notkins AL
    Arthritis Rheum; 1982 Apr; 25(4):396-400. PubMed ID: 6176247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon and interferon inactivators in patients with acquired immune deficiency syndrome and Kaposi's sarcoma. A preliminary report.
    Ikossi-O'Connor MG; Ambrus JL; West T; Lillie MA; Milgrom H; Chadha KC
    Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):271-7. PubMed ID: 6207572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological characterization of systemic lupus erythematosus in patients with circulating interferon and migration inhibitory factor.
    Rovenský J; Bosák V; Zitnan D; Lackovic V; Borecký L; Pekárek J; Svejcar J; Lukác J; Matoková M
    Int J Clin Pharmacol Res; 1984; 4(6):465-8. PubMed ID: 6085328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
    Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
    Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
    Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus.
    Song KS; Park YS; Kim HK
    Arthritis Rheum; 2000 Mar; 43(3):557-60. PubMed ID: 10728748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic activity in sera of patients with systemic lupus erythematosus.
    Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M
    Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
    el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
    Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human acid-labile interferon alpha.
    Piasecki E
    Arch Immunol Ther Exp (Warsz); 1999; 47(2):89-98. PubMed ID: 10202561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.